Skip to content

SciencePeriodic Labs

Periodic Labs

AI scientists paired with autonomous labs to discover new materials.

Category
Science
Pricing
PAID
Hosting
Cloud
Platforms
Web
Verified
Jun 14, 2026

Periodic Labs is building AI scientists and the autonomous laboratories for them to operate, automating hypothesis generation, experiments, and analysis across the physical sciences. Its initial targets include discovering higher-temperature superconductors and new materials for chipmakers. It is a research-stage company deploying with industry partners rather than a self-serve product.

Pros & cons

  • Founders behind ChatGPT & GNoME
  • $300M seed runway
  • Owns autonomous labs
  • Tackles superconductors
  • No public product
  • Research-stage
  • Opaque pricing
  • Long time horizon

Tags

Further reading

View all Science
  • View Isomorphic Labs details
    SciencePAID

    Isomorphic Labs

    Isomorphic Labs

    AI-first drug design built on AlphaFold for pharma R&D.

    Isomorphic Labs is an AI-first drug discovery company spun out of Google DeepMind, building generative and predictive ML models for molecular design and drug-performance prediction. Its Drug Design Engine builds on AlphaFold to advance internal and partnered pipelines with Eli Lilly, Novartis, and J&J. It is a drug-discovery company that works through pharma R&D partnerships rather than a self-serve product.

    Worth knowing

    DeepMind spinout (2021); raised a $600M Series A led by Thrive Capital with Alphabet and GV in March 2025 — its first external capital.

    • drug-discovery
    • alphafold
    • protein
    • biotech
  • View Lila Sciences details
    SciencePAID

    Lila Sciences

    Lila Sciences

    Autonomous AI labs pursuing scientific superintelligence.

    Lila Sciences is building a 'scientific superintelligence' platform that pairs a proprietary AI model with autonomous AI Science Factory lab instruments to generate hypotheses, design and run experiments, and learn in real time. It offers Catalyst, which augments existing R&D, and Creation, for new discoveries, across materials, therapeutics, chemicals, and energy. It is a platform and research company engaged through partnership rather than self-serve.

    Worth knowing

    Founded inside Flagship Pioneering; unveiled March 2025 and has since raised about $550M for its 'scientific superintelligence' bet.

    • autonomous-lab
    • materials
    • drug-discovery
    • scientific-ai
  • View EvolutionaryScale details
    ScienceFREEMIUMOpen core

    EvolutionaryScale

    EvolutionaryScale

    Frontier protein language models (the ESM family) for biology.

    EvolutionaryScale builds frontier protein language models — the ESM family, including ESM3, which reasons jointly over sequence, structure, and function. ESM3-open ships open weights and code under a non-commercial license, while larger models are served via its Forge API and AWS/NVIDIA partnerships. It is both an open-model provider and an API platform for protein design and understanding.

    Worth knowing

    Founded in 2023 by ex-Meta FAIR scientists after Meta cut its protein team; launched ESM3 with a $142M seed round.

    • protein-language-model
    • esm3
    • biotech
    • open-weights